BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 20959827)

  • 1. Socioeconomic position and participation in colorectal cancer screening.
    Frederiksen BL; Jørgensen T; Brasso K; Holten I; Osler M
    Br J Cancer; 2010 Nov; 103(10):1496-501. PubMed ID: 20959827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
    Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
    van de Schootbrugge-Vandermeer HJ; Lansdorp-Vogelaar I; de Jonge L; van Vuuren AJ; Dekker E; Spaander MCW; Ramakers CRB; Nagtegaal ID; van Kemenade FJ; van Leerdam ME; Toes-Zoutendijk E
    Eur J Cancer; 2023 Sep; 190():112942. PubMed ID: 37406529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
    Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS
    Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
    Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
    Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide.
    de Klerk CM; Gupta S; Dekker E; Essink-Bot ML;
    Gut; 2018 Apr; 67(4):679-687. PubMed ID: 28073892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic predictors of participation in colorectal cancer screening.
    Deding U; Henig AS; Salling A; Torp-Pedersen C; Bøggild H
    Int J Colorectal Dis; 2017 Aug; 32(8):1117-1124. PubMed ID: 28501944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal occult blood test screening uptake among immigrants from Muslim majority countries: A retrospective cohort study in Ontario, Canada.
    Vahabi M; Lofters A; Wong JP; Ellison L; Graves E; Damba C; Glazier RH
    Cancer Med; 2019 Nov; 8(16):7108-7122. PubMed ID: 31568705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
    von Wagner C; Baio G; Raine R; Snowball J; Morris S; Atkin W; Obichere A; Handley G; Logan RF; Rainbow S; Smith S; Halloran S; Wardle J
    Int J Epidemiol; 2011 Jun; 40(3):712-8. PubMed ID: 21330344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study.
    Pallesen AVJ; Herrstedt J; Westendorp RGJ; Mortensen LH; Kristiansen M
    Acta Oncol; 2021 Mar; 60(3):323-332. PubMed ID: 33427545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population.
    Dharni N; Armstrong D; Chung-Faye G; Wright AJ
    Health Expect; 2017 Aug; 20(4):608-617. PubMed ID: 27550367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening knowledge, attitudes and behavioural intention among Indigenous Western Australians.
    Christou A; Thompson SC
    BMC Public Health; 2012 Jul; 12():528. PubMed ID: 22809457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
    Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.